Literature DB >> 18500535

Expression and intracellular localization of matrix metalloproteinases in intraductal papillary mucinous neoplasms of the pancreas.

Urara Tamahashi1, Jiro Kumagai, Touichiro Takizawa, Masaki Sekine, Yoshinobu Eishi.   

Abstract

To analyze the expression of matrix metalloproteinases (MMPs) and their relationships with the histological grades of the intraductal papillary mucinous neoplasm (IPMN) of the pancreas, we examined the frequency of expression and intracellular localization of MMP1, MMP2, MMP3, MMP7, and MMP9 in IPMN by immunohistochemistry. A total of 45 IPMN lesions (14 adenomas, 17 borderline lesions, nine noninvasive carcinomas, and five invasive lesions) from 21 patients were examined. MMP1, MMP2, MMP7, and MMP9 were expressed in tumor cells. Frequency of tumor cells expressing MMP7 was low in adenomas (median, 5.0%), higher in borderline lesions (median, 30.0%), in noninvasive carcinomas (median, 50.0%), and in invasive lesions (median, 80.0%), with a significant trend (P < 0.0001). Such a trend was also observed when the lesions were classified into gastric and intestinal subtypes (P < 0.0001 and P = 0.011, respectively). Basolateral expression of MMP7 in tumor cells was more prominent in lesions with higher histological grades (P < 0.0001). The frequency and the localization of MMP1, MMP2, and MMP9 did not correlate to the histological grades. MMP7 may contribute to the process by which IPMN advances from adenoma to carcinoma and to subsequent invasion of tumor cells in IPMN.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18500535     DOI: 10.1007/s00428-008-0617-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  13 in total

1.  Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.

Authors:  Shigeru Sasaki; Hiroyuki Yamamoto; Hiroyuki Kaneto; Itaru Ozeki; Yasuyo Adachi; Hideyasu Takagi; Takeshi Matsumoto; Hideto Itoh; Tatsuya Nagakawa; Hiroyuki Miyakawa; Shunji Muraoka; Akira Fujinaga; Toshihiro Suga; Masaaki Satoh; Fumio Itoh; Takao Endo; Kohzoh Imai
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

2.  Ductal metaplasia of human exocrine pancreas and its association with carcinoma.

Authors:  I Parsa; D S Longnecker; D G Scarpelli; P Pour; J K Reddy; M Lefkowitz
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

3.  Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.

Authors:  Toru Furukawa; Günter Klöppel; N Volkan Adsay; Jorge Albores-Saavedra; Noriyoshi Fukushima; Akira Horii; Ralph H Hruban; Yo Kato; David S Klimstra; Daniel S Longnecker; Jutta Lüttges; G Johan A Offerhaus; Michio Shimizu; Makoto Sunamura; Arief Suriawinata; Kyoichi Takaori; Suguru Yonezawa
Journal:  Virchows Arch       Date:  2005-08-09       Impact factor: 4.064

4.  Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells.

Authors:  Permila C Harrell; Lisa J McCawley; Barbara Fingleton; J Oliver McIntyre; Lynn M Matrisian
Journal:  Exp Cell Res       Date:  2004-11-02       Impact factor: 3.905

5.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

Authors:  H Yamamoto; F Itoh; S Iku; Y Adachi; H Fukushima; S Sasaki; M Mukaiya; K Hirata; K Imai
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

6.  Matrix metalloproteinases: biologic activity and clinical implications.

Authors:  A R Nelson; B Fingleton; M L Rothenberg; L M Matrisian
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

Review 7.  Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials.

Authors:  Mark Bloomston; Emmanuel E Zervos; Alexander S Rosemurgy
Journal:  Ann Surg Oncol       Date:  2002-08       Impact factor: 5.344

Review 8.  Matrix metalloproteinases in tumor-host cell communication.

Authors:  Conor C Lynch; Lynn M Matrisian
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

9.  Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor.

Authors:  Conor C Lynch; Tracy Vargo-Gogola; Michelle D Martin; Barbara Fingleton; Howard C Crawford; Lynn M Matrisian
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

Review 10.  New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.

Authors:  Matthew F Leeman; Stephanie Curran; Graeme I Murray
Journal:  J Pathol       Date:  2003-12       Impact factor: 7.996

View more
  4 in total

1.  Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.

Authors:  Jian Zheng; Jonathan M Hernandez; Alexandre Doussot; Linda Bojmar; Constantinos P Zambirinis; Bruno Costa-Silva; Elke J A H van Beek; Milica T Mark; Henrik Molina; Gokce Askan; Olca Basturk; Mithat Gonen; T Peter Kingham; Peter J Allen; Michael I D'Angelica; Ronald P DeMatteo; David Lyden; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2018-01-12       Impact factor: 3.647

2.  Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy.

Authors:  Richard Fischer; Matthias Breidert; Tobias Keck; Frank Makowiec; Christian Lohrmann; Jan Harder
Journal:  Saudi J Gastroenterol       Date:  2012 Mar-Apr       Impact factor: 2.485

3.  Cysteamine suppresses invasion, metastasis and prolongs survival by inhibiting matrix metalloproteinases in a mouse model of human pancreatic cancer.

Authors:  Toshio Fujisawa; Benjamin Rubin; Akiko Suzuki; Prabhudas S Patel; William A Gahl; Bharat H Joshi; Raj K Puri
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

4.  Expression of matrix metalloproteinase-7 correlates with the invasion of T1 colorectal carcinoma.

Authors:  Fumihiko Urushibara; Eisuke Shiozawa; Hideyuki Miyachi; Masashi Misawa; Tomonari Cho; Yusuke Takehara; Nana Arai; Toshitaka Funaki; Sakiko Tazawa; Mayumi Homma; Tomoko Norose; Mutsuko Omatsu; Toshiko Yamochi; Toshiaki Kunimura; Genshu Tate; Kazuho Honda; Ishida Fumio; Shin-Ei Kudo; Masafumi Takimoto
Journal:  Oncol Lett       Date:  2018-01-08       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.